Astellas to Present Data on Long-Term Outcomes and Clinical Use of Its Portfolio Across Disease Stages at ASCO 2026

B 10 abstracts, including two oral presentations, reinforceĀ Astellas’ long-term commitment to advancing oncology care TOKYO, May 18, 2026 /PRNewswire/ — Astellas Pharma Inc. (TSE: 4503,…
posteditor
posteditor
Articles: 21727

Other News